Kodach LL, Peppelenbosch MP. Targeting the myeloid-derived suppressor cell compartment for inducing
responsiveness to immune-checkpoint blockade is best limited to specific subtypes
of gastric cancer. Gastroenterology 2021 Mar 30. pii: S0016-5085(21)00574.
PMID: 33798523